High-throughput single-cell sequencing technologies have ushered in an era of precision medicine, achieving a level of detail and specificity in medical research and treatment that was previously unattainable.
Growing evidence from publications and case studies in the field of oncology, immunology, infectious diseases, and drug development, indicate the groundbreaking diagnostic potential of single cell technologies.
Tumor heterogeneity is a significant obstacle in the efficacy of cancer treatments, encompassing genomic diversity, transcriptomic variations, and disparities in the immune microenvironment. This complexity often impedes the success of therapeutic interventions.
The immune system is highly complex, encompassing more than just the classification of immune cells. The potency of these cells and their activation, inhibition, and exhaustion significantly impact immune responses. This intricacy extends beyond infectious and autoimmune diseases, affecting immune reactions post-transplantation.
In the realm of neurology, where the complexity of the human brain presents an array of challenges, the advent of single-cell sequencing technology has sparked a revolution. This cutting-edge methodology allows researchers to delve into the intricate landscape of the brain at a level of detail previously unimaginable.
Are you planning a project with difficult tissue types? Being a pioneer is not easy, but we are here to help!
Our Application Notes provide insight into specific use cases of our end-to-end solutions.